Alumis (ALMS) Stock
$6.03
+3.08% Close Nov 6
Open interactive chartALMS stock price and performance
ALMS stock closed at $6.03 on Nov 6, 2026. The tables below use that final daily session.
- Last close
- $6.03
- Day range
- $5.82 to $6.08
- 52-week range
- $4.40 to $31.35
- From 52-week high
- −80.8%
- Average volume (50 days)
- 3.3M
- 1 week
- −10.4%
- 1 month
- −13.5%
- 3 months
- −78.1%
- Year to date
- −38.2%
- 1 year
- +32.0%
- 3 years
- –
- 5 years
- –
Is ALMS stock in an uptrend?
No, ALMS stock is in a downtrend: it does not meet the Minervini Trend Template criteria and neither Daily Pivot Breakout momentum filter is active. Price is below its 200-day moving average.
- Daily Pivot momentum filters
- 0 of 2 active
- 100-day ROC
- −73.0% filter at 40%: off
- 100-day EMA slope
- −36.2% filter at 25%: off
- Trend state
- Downtrend
- Minervini Trend Template
- Not met on the latest scan
- 50-day average
- Below
- 150-day average
- Below
- 200-day average
- Below
- 200-day slope (1 month)
- −5.01%
- ATR (14) % of price
- 7.37%
Momentum filters from the Daily Pivot Breakout indicator: 100-day rate of change and 100-day EMA slope, each against its minimum.
Is ALMS stock in a Stage 2 uptrend?
No, ALMS stock is in a Stage 4 decline by our Weinstein stage analysis: its price is below a falling 30-week moving average.
- Weinstein stage
- Stage 4 (declining)
- 30-week SMA
- $19.08
- 30-week slope (4 weeks)
- −10.98%
- Mansfield RS vs SPY
- -69.43
Weinstein stage analysis uses weekly closes against the 30-week moving average and Mansfield relative strength versus SPY. See the free Stage 2 stocks screener.
ALMS support and resistance levels
| Level | Price | From close |
|---|---|---|
| 200-day SMA | $20.94 | +247.3% |
| 150-day SMA | $19.19 | +218.3% |
| 30-week SMA | $19.08 | +216.4% |
| 50-day SMA | $8.13 | +34.8% |
| Daily Pivot resistance (pivot high) | $7.25 | +20.2% |
| 21-day EMA | $6.81 | +13.0% |
| 9-day EMA | $6.39 | +5.9% |
| Latest Daily Pivot low | $6.01 | −0.3% |
Levels above the close act as resistance, levels below as support. Last close $6.03.
ALMS breakout and scanner signals
| Scanner | Last signal (free view, 5 sessions late) | Past year |
|---|---|---|
| VCP | Feb 18, 2026 | 4 |
| RSI Divergence | Sep 25, 2026 | 3 |
| Weinstein Stage Analysis | Aug 17, 2026 | 157 |
| Daily Pivot Breakout | Jun 29, 2026 | 4 |
| Minervini Trend Template | Aug 10, 2026 | 93 |
| Episodic Pivot | Jan 6, 2026 | 1 |
| Ichimoku TK cross | Aug 3, 2026 (bearish) | 8 |
| 9/21 EMA cross | Aug 11, 2026 (bearish) | 7 |
| Golden / Death Cross | Sep 18, 2026 (bearish) | 2 |
| RS Rating | Aug 31, 2026 | 171 |
ALMS earnings history
| Reported | EPS estimate | EPS actual | Surprise |
|---|---|---|---|
| Aug 13, 2026 | $-0.71 | $-0.79 | −11.3% |
| May 14, 2026 | $-0.77 | $-0.74 | +3.9% |
| Mar 31, 2026 | $0.59 | $0.66 | +11.9% |
| Mar 19, 2026 | $-0.98 | $-0.25 | +74.5% |
ALMS bull and bear case
What looks strong
- No strong points in the trend data on the latest scan.
What looks weak
- Neither Daily Pivot momentum filter is active (100-day ROC -73.0%, 100-day EMA slope -36.2%; the filters need 40% and 25%).
- Does not meet the Minervini Trend Template on the latest scan.
- Price is below the 200-day moving average, which is falling.
- Short interest is 14.27% of shares outstanding.
- Net income over the last 12 months is negative.
Drawn only from the data on this page. Not a recommendation.
ALMS news and SEC filings, last 30 days
- 4Insider transaction (Form 4)
- 4Insider transaction (Form 4)
- 4Insider transaction (Form 4)
- 4Insider transaction (Form 4)
- 4Insider transaction (Form 4)
- 4Insider transaction (Form 4)
Source: SEC EDGAR.
ALMS insider trading and risks
- Buys, last 90 days
- 0 ($0)
- Sales, last 90 days
- 6 ($23,622)
- Buys, last 12 months
- 0 ($0)
- Sales, last 12 months
- 6 ($23,622)
| Date | Insider | Trade | Value |
|---|---|---|---|
| Nov 2 | Schroer John R.Chief Financial Officer | Sale 794 shares | $5,177 |
| Nov 2 | Hardiman Roy C.Chief Business & Strategy Ofcr | Sale 652 shares | $4,251 |
| Nov 2 | Goldstein David MChief Scientific Officer | Sale 629 shares | $4,101 |
| Nov 2 | Bradley Mark ChristopherChief Development Officer | Sale 623 shares | $4,062 |
| Nov 2 | Drappa JornChief Medical Officer | Sale 593 shares | $3,866 |
Risk flags from the data
- Short interest is 14.27% of shares outstanding.
- Net income over the last 12 months is negative.
Insider trades: SEC Form 4 open-market purchases and sales.
ALMS valuation and fundamentals
- Market cap
- $780.5M
- Enterprise value
- $291.3M
- P/E (trailing)
- 0.2
- P/E (forward)
- -2.1
- PEG
- 0.00
- Price to sales
- 105.50
- Price to book
- 1.71
- EV to EBITDA
- -0.7
- Gross margin
- –
- Operating margin
- −6,439.9%
- Profit margin
- 0.0%
- Return on equity
- −93.6%
- Revenue (TTM)
- $7.4M
- Revenue growth (quarter, y/y)
- −37.7%
- Cash
- $502.3M
- Debt
- $36.4M
- Beta
- -0.27
| Fiscal year | Revenue | Net income | Free cash flow |
|---|---|---|---|
| 2025 | $24.1M | −$243.3M | −$369.5M |
| 2024 | $0 | −$294.2M | −$266.6M |
| 2023 | $0 | −$155.0M | −$148.4M |
| 2022 | $0 | −$111.9M | −$106.7M |
ALMS dividends and splits
- Dividend yield
- 0.00%
Who owns ALMS?
- Shares outstanding
- 128.5M
- Float
- 91.3M
- Held by insiders
- +0.5%
- Held by institutions
- +94.3%
- Short interest (% of shares)
- +14.3%
- Days to cover
- 4.2
What does Alumis Inc. do?
- CEO
- Mr. Martin Babler Ph.D.
- Employees
- 237
- Headquarters
- South San Francisco, CA, United States
- Website
- alumis.com
